"We remain concerned that your... adverse drug experience reporting system has not been fully validated, and may have resulted in inaccurate assessment and untimely submission of 15-day alerts," FDA said (as quoted by Reuters).
Any details about the adverse drug experience reporting system in use would be appreciated.
Any details about the adverse drug experience reporting system in use would be appreciated.